Skip to main content
Clinical Trials/IRCT20210310050669N1
IRCT20210310050669N1
Completed
Phase 2

Effect of Crocin on macular and optic nerve head vascular density in non-proliferative diabetic retinopathy patient with non-central macular involvement

Mashhad University of Medical Sciences0 sites24 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
24
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Adult patients (18 years and older) with type 2 diabetes without central involvement macular edema according to ETDRS criteria (early treatment diabetic retinopathy study) in the studied eye
  • Best corrective visual acuity equal or upper than 7/10 (20/30\) according to Snellen chart
  • HbA1c has been 6\.5\-9\.5 during the last 3 months
  • No need for standard treatment including Injection, Macula Laser or Retina Laser
  • The absence of other serious illnesses, such as liver and kidney failure
  • The maximum severity of diabetic retinopathy be non\- proliferative
  • Controlled blood pressure or lipid profile in hypertension and hyperlipidemia patients if present

Exclusion Criteria

  • The presence of other ophthalmic diseases that effects macular edema (like Retinal vein occlusion, uveitis, Epiretinal membrane)
  • Patients with anterior segmentation of the eye disorders (Cornea, anterior chamber, Iris, and lens)
  • History of any intraocular surgery except cataract surgery (more than 6 months before entrance study)
  • Sub foveal hard exudates deposition
  • Pregnancy, Breast feeding
  • Need for Standard treatment including Injection, Macula Laser, or Retina Laser
  • Allergy to saffron
  • The presence of other ophthalmic diseases that effects vision (glaucoma, vascular obstruction, macular pathology)

Outcomes

Primary Outcomes

Not specified

Similar Trials